Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

883 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics of naftidrofuryl in patients with renal impairment.
Legallicier B, Barbier S, Bolloni L, Fillastre JP, Godin M, Kuhn T, Porte F, Chretien P, Dupain T, Bromet-Petitd M. Legallicier B, et al. Among authors: kuhn t. Arzneimittelforschung. 2005;55(7):370-5. doi: 10.1055/s-0031-1296874. Arzneimittelforschung. 2005. PMID: 16080275
Reply - Letter to the Editor - "Adherence to a healthful plant-based diet and risk of mortality among individuals with chronic kidney disease: A prospective cohort study".
Thompson AS, Gaggl M, Bondonno NP, Jennings A, O'Neill JK, Hill C, Karavasiloglou N, Rohrmann S, Cassidy A, Kühn T. Thompson AS, et al. Among authors: kuhn t. Clin Nutr. 2024 Nov 22;44:16-18. doi: 10.1016/j.clnu.2024.11.033. Online ahead of print. Clin Nutr. 2024. PMID: 39608083 No abstract available.
Palbociclib in combination with either aromatase inhibitors or fulvestrant for patients with advanced HR+/HER2- breast cancer in Germany - Final results of the phase 2 multicohort INGE-B trial.
Welslau M, Potthoff K, Zaiss M, Müller L, Brucker C, Salat C, Untch M, Meiler J, Lüftner D, Welt A, Dörfel S, Hagen V, Stein A, Liersch R, Kuhn T, Siebenbach HU, Bing G, Vannier C, Marschner N, Gratzke K. Welslau M, et al. Among authors: kuhn t. Oncol Res Treat. 2024 Nov 15:1-20. doi: 10.1159/000542459. Online ahead of print. Oncol Res Treat. 2024. PMID: 39551040 Free article.
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study.
Montagna G, Laws A, Ferrucci M, Mrdutt MM, Sun SX, Bademler S, Balbaloglu H, Balint-Lahat N, Banys-Paluchowski M, Barrio AV, Benson J, Bese N, Boughey JC, Boyle MK, Diego EJ, Eden C, Eller R, Goldschmidt M, Hlavin C, Heidinger M, Jelinska J, Karadeniz Cakmak G, Kesmodel SB, King TA, Kuerer HM, Loesch J, Milardi F, Murawa D, Moo TA, Menes TS, Passeri D, Pastoriza JM, Perhavec A, Pislar N, Polidorio N, Rami A, Ryu JM, Schulz A, Sevilimedu V, Ugurlu MU, Uras C, van Hemert A, Wong SM, Yoo TR, Zhang JQ, Karanlik H, Cabioğlu N, Peeters MV, Morrow M, Weber WP; ICARO Study Group. Montagna G, et al. J Clin Oncol. 2024 Nov 7:JCO2401052. doi: 10.1200/JCO.24.01052. Online ahead of print. J Clin Oncol. 2024. PMID: 39509672
883 results